Log in to save to my catalogue

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_744720946

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant

About this item

Full title

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant

Publisher

London, England: SAGE Publications

Journal title

Journal of oncology pharmacy practice, 2008-09, Vol.14 (3), p.157-162

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Purpose. Ifosfamide is metabolized by the cytochrome P450 system to its active form, ifosforamide mustard. A potential side effect is neurotoxicity, often manifesting as confusion, hallucination, or seizure. Aprepitant, a neurokinin-1 inhibitor, is recommended for highly and moderately emetogenic chemotherapy regimens and may interfere with the met...

Alternative Titles

Full title

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_744720946

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_744720946

Other Identifiers

ISSN

1078-1552

E-ISSN

1477-092X

DOI

10.1177/1078155208093930

How to access this item